These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 754273)

  • 1. [Immunity against measles in the Granada Province and control by vaccination of susceptible persons].
    Maroto Vela MC; Pérez Mora MD; Gálvez Vargas R; Piedrola Angulo G
    Rev Sanid Hig Publica (Madr); 1978; 52(7-8):967-74. PubMed ID: 754273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination].
    Colomer Pache M; Arnedo Pena A
    Med Clin (Barc); 1988 Nov; 91(17):649-52. PubMed ID: 3230970
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
    abu Eldan J; Borćić B; Smerdel S
    Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate age for measles vaccination in the United States.
    Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
    Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent deliberations on vaccination against measles in Denmark].
    Zoffmann H; Koch C
    Ugeskr Laeger; 1982 Jan; 144(3):137-41. PubMed ID: 7043842
    [No Abstract]   [Full Text] [Related]  

  • 10. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eradication of measles. Synthesis outline].
    Amela C
    Rev Esp Salud Publica; 1999; 73(5):639-43. PubMed ID: 10650757
    [No Abstract]   [Full Text] [Related]  

  • 15. [Performance of vaccinations against poliomyelitis and measles in Malopolska province versus the plan for eradication and elimination of these diseases].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2001; 55(3):355-63. PubMed ID: 11761843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
    An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is it necessary to vaccinate against measles?].
    Celers J
    Arch Fr Pediatr; 1981 Nov; 38(9):651-2. PubMed ID: 7332428
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles: effect of a two-dose vaccination programme in Catalonia, Spain.
    Godoy P; Domínguez A; Salleras L
    Bull World Health Organ; 1999; 77(2):132-7. PubMed ID: 10083711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal age for vaccinating Zimbabwean children against measles.
    Mhere OT; Mhlanga GE; Spencer HR
    Cent Afr J Med; 1984 Nov; 30(11):209-11. PubMed ID: 6529744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Measles and measles vaccination in Brazil. Magnitude of the problem and contribution to the method of small doses in mass immunization. Clinico-serological evaluation of 2 types of highly attenuated vaccine].
    Veronesi R; Penna HA; Issler H; Braga Nde P; de Carvalho PR; Oria H; Monetti V
    Hospital (Rio J); 1967 Oct; 72(4):1203-32. PubMed ID: 5306984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.